Suchergebnisse - "Miralpeix, Anna"

PubPharm (9)

1

Influence of language barrier and cultural background in hepatitis B disease knowledge in a Chinese community of Spain

enthalten in: Frontiers in public health | 2024

von Pocurull, A. | Collazos, C. | Miralpeix, A. | +6

2

Influence of language barrier and cultural background in Hepatitis B disease knowledge in a Chinese community of Spain.

enthalten in: ResearchSquare.com | 2023

von Pocurull, A. | Tapias, L. | Wang, T. | +6

3

Health-Related Quality of Life in Patients Living with Wilson Disease in Spain : A Cross-Sectional Observational Study

enthalten in: Journal of clinical medicine | 2023

von Mariño, Z. | Berenguer, M. | Peña-Quintana, L. | +11

4

Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test-and-treat program

enthalten in: Journal of medical virology | 2023

von Not, A. | Saludes, V. | Gálvez, M. | +11

5

Usefulness of dried blood spot samples for monitoring hepatitis C treatment outcome and reinfection among people who inject drugs in a test‐and‐treat program

enthalten in: Journal of Medical Virology | 2023

von Not, A. | Saludes, V. | Gálvez, M. | +11

6

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

enthalten in: JHEP reports : innovation in hepatology | 2022

von Lens, S. | Miralpeix, A. | Gálvez, M. | +9

7

Low risk of hepatitis B reactivation in patients with severe COVID-19 who receive immunosuppressive therapy

enthalten in: Journal of viral hepatitis | 2021

von Rodríguez-Tajes, S. | Miralpeix, A. | Costa, J. | +6

CommentIn: Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):799-801. - PMID 37084117

8

Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy

enthalten in: Journal of Viral Hepatitis | 2021

von Rodríguez‐Tajes, S. | Miralpeix, A. | Costa, J. | +6

9

Effectiveness of a primary care-based intervention to reduce sitting time in overweight and obese patients (SEDESTACTIV) : a randomized controlled trial; rationale and study design

enthalten in: BMC public health | 2014

von Martín-Borràs, C. | Giné-Garriga, M. | Martínez, E. | +78

1
[1]